Norepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors

Stefka Gyoneva1, Stephen F Traynelis

  • 1Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

Insights

Norepinephrine (NE) influences microglial cell movement in the brain. This neurotransmitter retracts microglial processes, impacting immune responses in neurodegenerative diseases and brain injury.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are the central nervous system's (CNS) immune cells, crucial for monitoring brain homeostasis.
  • Neuroinflammation in neurodegenerative diseases is linked to norepinephrine (NE) loss.
  • Microglial process dynamics are key to their surveillance and response functions.

Purpose of the Study:

  • To investigate the effects of norepinephrine (NE) on microglial process dynamics in the brain.
  • To identify the specific adrenergic receptors involved in NE-mediated microglial responses.
  • To explore the interaction between adrenergic and purinergic signaling in microglia.

Main Methods:

  • High-resolution analysis of microglial process dynamics in acute mouse brain slices.
  • Quantitative PCR to determine adrenergic receptor expression in microglia.
  • Experiments using subtype-selective adrenergic receptor agonists and antagonists.
  • Co-application of NE with ATP to assess signaling cross-talk.

Main Results:

  • Norepinephrine (NE) caused significant retraction of microglial processes in brain slices.
  • Resting microglia primarily express β2 adrenergic receptors, while LPS-activated microglia upregulate α2A receptors.
  • Both resting and activated microglia showed process retraction upon NE stimulation in vitro.
  • β2 receptors mediate NE effects in resting microglia, and α2A receptors in activated microglia.
  • NE blocked ATP-induced microglial process extension and migration, indicating cross-talk between NE and purinergic signaling.

Conclusions:

  • The neurotransmitter norepinephrine (NE) modulates microglial motility via specific adrenergic receptors (β2 and α2A).
  • Cross-talk exists between adrenergic and purinergic signaling pathways in microglia.
  • NE's modulation of microglial motility may influence brain immune responses in various pathological conditions.

Related Concept Videos

Adrenergic Neurons: Neurotransmission01:27

Adrenergic Neurons: Neurotransmission

Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Sympathetic Signaling01:31

Sympathetic Signaling

Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...